Loading...
LifeVantage Corp (LFVN) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company is facing significant financial challenges, with declining revenue, net income, and EPS. Additionally, technical indicators are bearish, and there are no recent positive catalysts or strong trading signals to support an immediate investment. It is better to wait for clearer signs of recovery or improved performance before considering a buy.
The technical indicators for LFVN are bearish. The MACD is below 0 and negatively contracting, RSI is neutral at 38.527, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot point of 4.845, with key support at 4.495 and resistance at 5.195.

NULL identified. There are no recent news updates or positive developments to act as a catalyst for the stock.
The company's financial performance in Q2 2026 showed significant declines in revenue (-27.79% YoY), net income (-89.18% YoY), and EPS (-89.47% YoY). Gross margin also dropped by 8.11%. Analysts have lowered the price target from $12 to $5 due to weaker-than-expected results and guidance. Technical indicators are bearish, and there is no recent positive sentiment from hedge funds, insiders, or Congress trading data.
In Q2 2026, LifeVantage reported a revenue decline of -27.79% YoY to $48.93M, net income dropped -89.18% YoY to $276K, and EPS fell -89.47% YoY to $0.02. Gross margin decreased by 8.11% to 74%. These figures indicate significant financial struggles and declining profitability.
Lake Street recently lowered the price target for LFVN from $12 to $5 while maintaining a Buy rating. The analyst believes valuation may have troughed and sees potential for recovery if the company can execute its revised FY26 guidance. However, the stock has dropped 25% after hours following the announcement, reflecting weak sentiment.